|
Description:
The
purpose of this research study is to find out how effective the SSRI antidepressant, citalopram (CIT), is administered over
a 16 week period with or without a targeted psychotherapy called Complicated Grief Therapy (CGT). Aftern medical and psychiatric
evaluations are completed, eligible subjects are randomly assigned to (that is, by chance) to one of 4 study treatments (with
a 1 in 4 chance of being assigned to each group): - Complicated Grief Therapy (CGT)
plus antidepressant medication (citalopram)
- CGT plus placebo (a pill without active medication)
- Medication (citalopram) without CGT
- Placebo without CGT
Key Eligibility Criteria - Individuals 18 years or
older with a primary diagnosis of Complicated Grief (as determined by the psychiatrists who conduct our initial screening
process).
- Physical examination and laboratory findings without clinically significant
medical problems.
- Pregnant or lactating women or those able to become pregnant not using
medically accepted forms of birth control cannot take part in the research study.
 |
If you are interested in participating: - Call the Center for Anxiety and Traumatic Stress Disorders:
1 (866) 44-WORRY
- Or
send an email to: anxietystudy@partners.org
|
